Renal Cell Carcinoma

• FDA approval · 2011-06-16
  FDA Approved: TORISEL — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

  FDA approves a supplemental application for Torisel (temsirolimus) from Wyeth Pharmaceuticals (Pfizer), related to an update to the product'…

• FDA approval · 2010-04-26
  FDA Approved: TORISEL — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

  FDA approved a supplemental application for Torisel (temsirolimus) submitted by Wyeth Pharmaceuticals LLC (a Pfizer subsidiary).

• FDA approval · 2009-10-19
  FDA Approved: VOTRIENT — Original Application (Novartis Pharmaceuticals Corporation)

  FDA approved VOTRIENT (pazopanib hydrochloride) under an Original Application for cancer indications, marking pazopanib’s initial approval.

• FDA approval · 2009-03-30
  FDA Approved: AFINITOR — Original Application (Novartis Pharmaceuticals Corporation)

  The FDA approved the original application for Afinitor (everolimus) from Novartis, granting marketing authorization for its use in treating …

• FDA approval · 2007-05-30
  FDA Approved: TORISEL — Original Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

  FDA approved temsirolimus (Torisel) in an original application for the treatment of advanced renal cell carcinoma.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.